Jeen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 12157.97%
(FY 2023)
- Profit 11642.11%
(FY 2023)
- Ebitda 14828.08%
(FY 2023)
- Net Worth 103952.32%
(FY 2023)
- Total Assets 11084.90%
(FY 2023)
About Jeen Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Tibrewal, Anup Tibrewal, and Ashish Tibrewal serve as directors at the Company.
- CIN/LLPIN
U51909WB2018PTC225865
- Company No.
225865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jeen Lifesciences Private Limited offer?
Jeen Lifesciences Private Limited offers a wide range of products and services, including Health Conditions, Mental Wellness.
Who are the key members and board of directors at Jeen Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Tibrewal  | Director | 26-Apr-2018 | Current |
| Anup Tibrewal | Director | 26-Apr-2018 | Current |
| Ashish Tibrewal | Director | 26-Apr-2018 | Current |
Financial Performance of Jeen Lifesciences.
Jeen Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12157.97% increase. The company also saw a substantial improvement in profitability, with a 11642.11% increase in profit. The company's net worth Soared by an impressive increase of 103952.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeen Lifesciences?
Unlock access to Jeen Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gayatripharma Med Private LimitedActive 17 years 6 monthsAnand Tibrewal, Anup Tibrewal and 1 more are mutual person
- Rpgupta Pharmamed Private LimitedActive 14 years 2 months
Anand Tibrewal, Anup Tibrewal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jeen Lifesciences?
Jeen Lifesciences has a workforce of 40 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
